NURS6630 FINAL EXAM 300 ACTUAL QUESTIONS
AND CORRECT ANSWERS WITH RATIONALE
LATEST UPDATE ASSURED PASS
This comprehensive set of 300 unique, multiple-choice questions is specifically
designed for the NURS6630 Final Exam on psychopharmacology and
psychiatric medication management. The questions cover all core topics
including antipsychotics, antidepressants, mood stabilizers, stimulants, and
medications for substance use disorders, anxiety, dementia, and pain
management. Each question is paired with a correct answer and a detailed,
evidence-based rationale that explains the pharmacodynamic and
pharmacokinetic principles, clinical indications, side effect profiles, and drug
interactions essential for safe prescribing. The content spans pediatric, adult,
and geriatric populations, ensuring thorough preparation for advanced
practice psychiatric-mental health nursing and psychopharmacology board
certification.
Question 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression
who needs to manage the top-down cortical control and the excessive drive from
striatal hyperactivity?
A. Stimulants
B. Antidepressants
C. Antipsychotics
D. SSRIs
Correct Answer: C
Rationale: Antipsychotics are the first-line treatment for psychotic aggression
because they can manage both the top-down cortical control and the excessive
drive from striatal hyperactivity. These medications block dopamine D2 receptors
in the striatum, reducing the excessive dopaminergic drive that contributes to
aggression and psychosis .
Question 2
,The PMHNP is selecting a medication treatment option for a patient who is
exhibiting psychotic behaviors with poor impulse control and aggression. Of the
available treatments, which can help temper some of the adverse effects or
symptoms that are normally caused by D2 antagonism?
A. First-generation, conventional antipsychotics
B. First-generation, atypical antipsychotics
C. Second-generation, conventional antipsychotics
D. Second-generation, atypical antipsychotics
Correct Answer: D
Rationale: Second-generation, atypical antipsychotics can help temper some of the
adverse effects or symptoms that are normally caused by D2 antagonism. These
medications have a lower affinity for D2 receptors and also block 5-HT2A
receptors, which can reduce extrapyramidal side effects and improve negative
symptoms compared to first-generation antipsychotics .
Question 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association
with aggressive behaviors in patients with the student. Why does the PMHNP
prescribe a standard dose of atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy
B. The doses are based on achieving a minimum of 80% D2 receptor occupancy
C. The doses are based on achieving 60% D2 receptor occupancy
D. None of the above
Correct Answer: C
Rationale: Standard doses of atypical antipsychotics are based on achieving
approximately 60% D2 receptor occupancy. This level is sufficient for therapeutic
effect while minimizing the risk of extrapyramidal side effects. Higher occupancy
levels (above 80%) are associated with increased risk of EPS .
Question 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line
treatment to the patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects
B. It can exaggerate the psychotic symptoms
C. Clozapine (Clozaril) should not be used as high-dose monotherapy
D. There is no documentation that clozapine (Clozaril) is effective for patients who
are violent
,Correct Answer: A
Rationale: Clozapine is avoided as a first-line treatment due to its significant risk
of serious adverse effects, including agranulocytosis, myocarditis, and seizures. It
requires regular blood monitoring and is typically reserved for treatment-resistant
schizophrenia or patients who have failed other antipsychotic trials .
Question 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made
by the PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS
B. Prescribing the patient 12 mg/day
C. Titrating the dose by increasing it every 5-7 days
D. Writing a prescription for a higher dose of oral risperidone (Risperdal) to
achieve high D2 receptor occupancy
Correct Answer: C
Rationale: Titrating the dose by increasing it every 5-7 days is the proper approach
for risperidone dosing. This allows for adequate assessment of therapeutic response
and side effects before further dose increases. High doses increase EPS risk, and
patients should be educated about potential side effects .
Question 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target
aggressive and impulsive symptoms by decreasing dopaminergic
neurotransmission. Which mood stabilizer will the PMHNP select?
A. Lithium (Lithane)
B. Phenytoin (Dilantin)
C. Valproate (Depakote)
D. Topiramate (Topamax)
Correct Answer: C
Rationale: Valproate (Depakote) is a mood stabilizer that decreases dopaminergic
neurotransmission, making it effective for targeting aggressive and impulsive
symptoms. It also enhances GABAergic transmission, which contributes to its
mood-stabilizing and anti-aggressive effects. Lithium affects multiple
neurotransmitter systems but is not primarily dopaminergic .
Question 7
The PMHNP is assessing a patient who presents with symptoms of dementia.
Before the PMHNP considers treatment options, the patient must be assessed for
, other possible causes of dementia. Which of the following answers addresses both
possible other causes of dementia and a rational treatment option for dementia?
A. Possible other causes: hypothyroidism, adrenal insufficiency,
hyperparathyroidism. Possible treatment option: donepezil
B. Possible other causes: vitamin B12 deficiency, depression. Possible treatment
option: memantine
C. Possible other causes: normal pressure hydrocephalus, syphilis. Possible
treatment option: rivastigmine
D. Possible other causes: hyperthyroidism, vitamin D deficiency. Possible
treatment option: galantamine
Correct Answer: A
Rationale: Hypothyroidism, adrenal insufficiency, and hyperparathyroidism are
reversible causes of dementia that must be ruled out before initiating treatment.
Donepezil is a cholinesterase inhibitor that is a rational first-line treatment option
for dementia, particularly Alzheimer's disease .
Question 8
An 80-year-old female patient diagnosed with Stage II Alzheimer's has a history of
irritable bowel syndrome. Which cholinergic drug may be the best choice for
treatment given the patient's gastrointestinal problems?
A. Donepezil (Aricept)
B. Rivastigmine (Exelon)
C. Galantamine (Razadyne)
D. Memantine (Namenda)
Correct Answer: A
Rationale: Donepezil (Aricept) is often the best choice for patients with
gastrointestinal problems because it has a more favorable GI side effect profile
compared to rivastigmine and galantamine. It is a selective acetylcholinesterase
inhibitor with once-daily dosing and lower incidence of GI adverse effects .
Question 9
The PMHNP is teaching parents about their child's new prescription for Ritalin.
What will the PMHNP include in the teaching?
A. The second dose should be taken at lunch
B. There are no risks for insomnia
C. There is only one daily dose, to be taken in the morning
D. There will be continued effects into the evening
AND CORRECT ANSWERS WITH RATIONALE
LATEST UPDATE ASSURED PASS
This comprehensive set of 300 unique, multiple-choice questions is specifically
designed for the NURS6630 Final Exam on psychopharmacology and
psychiatric medication management. The questions cover all core topics
including antipsychotics, antidepressants, mood stabilizers, stimulants, and
medications for substance use disorders, anxiety, dementia, and pain
management. Each question is paired with a correct answer and a detailed,
evidence-based rationale that explains the pharmacodynamic and
pharmacokinetic principles, clinical indications, side effect profiles, and drug
interactions essential for safe prescribing. The content spans pediatric, adult,
and geriatric populations, ensuring thorough preparation for advanced
practice psychiatric-mental health nursing and psychopharmacology board
certification.
Question 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression
who needs to manage the top-down cortical control and the excessive drive from
striatal hyperactivity?
A. Stimulants
B. Antidepressants
C. Antipsychotics
D. SSRIs
Correct Answer: C
Rationale: Antipsychotics are the first-line treatment for psychotic aggression
because they can manage both the top-down cortical control and the excessive
drive from striatal hyperactivity. These medications block dopamine D2 receptors
in the striatum, reducing the excessive dopaminergic drive that contributes to
aggression and psychosis .
Question 2
,The PMHNP is selecting a medication treatment option for a patient who is
exhibiting psychotic behaviors with poor impulse control and aggression. Of the
available treatments, which can help temper some of the adverse effects or
symptoms that are normally caused by D2 antagonism?
A. First-generation, conventional antipsychotics
B. First-generation, atypical antipsychotics
C. Second-generation, conventional antipsychotics
D. Second-generation, atypical antipsychotics
Correct Answer: D
Rationale: Second-generation, atypical antipsychotics can help temper some of the
adverse effects or symptoms that are normally caused by D2 antagonism. These
medications have a lower affinity for D2 receptors and also block 5-HT2A
receptors, which can reduce extrapyramidal side effects and improve negative
symptoms compared to first-generation antipsychotics .
Question 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association
with aggressive behaviors in patients with the student. Why does the PMHNP
prescribe a standard dose of atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy
B. The doses are based on achieving a minimum of 80% D2 receptor occupancy
C. The doses are based on achieving 60% D2 receptor occupancy
D. None of the above
Correct Answer: C
Rationale: Standard doses of atypical antipsychotics are based on achieving
approximately 60% D2 receptor occupancy. This level is sufficient for therapeutic
effect while minimizing the risk of extrapyramidal side effects. Higher occupancy
levels (above 80%) are associated with increased risk of EPS .
Question 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line
treatment to the patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects
B. It can exaggerate the psychotic symptoms
C. Clozapine (Clozaril) should not be used as high-dose monotherapy
D. There is no documentation that clozapine (Clozaril) is effective for patients who
are violent
,Correct Answer: A
Rationale: Clozapine is avoided as a first-line treatment due to its significant risk
of serious adverse effects, including agranulocytosis, myocarditis, and seizures. It
requires regular blood monitoring and is typically reserved for treatment-resistant
schizophrenia or patients who have failed other antipsychotic trials .
Question 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made
by the PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS
B. Prescribing the patient 12 mg/day
C. Titrating the dose by increasing it every 5-7 days
D. Writing a prescription for a higher dose of oral risperidone (Risperdal) to
achieve high D2 receptor occupancy
Correct Answer: C
Rationale: Titrating the dose by increasing it every 5-7 days is the proper approach
for risperidone dosing. This allows for adequate assessment of therapeutic response
and side effects before further dose increases. High doses increase EPS risk, and
patients should be educated about potential side effects .
Question 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target
aggressive and impulsive symptoms by decreasing dopaminergic
neurotransmission. Which mood stabilizer will the PMHNP select?
A. Lithium (Lithane)
B. Phenytoin (Dilantin)
C. Valproate (Depakote)
D. Topiramate (Topamax)
Correct Answer: C
Rationale: Valproate (Depakote) is a mood stabilizer that decreases dopaminergic
neurotransmission, making it effective for targeting aggressive and impulsive
symptoms. It also enhances GABAergic transmission, which contributes to its
mood-stabilizing and anti-aggressive effects. Lithium affects multiple
neurotransmitter systems but is not primarily dopaminergic .
Question 7
The PMHNP is assessing a patient who presents with symptoms of dementia.
Before the PMHNP considers treatment options, the patient must be assessed for
, other possible causes of dementia. Which of the following answers addresses both
possible other causes of dementia and a rational treatment option for dementia?
A. Possible other causes: hypothyroidism, adrenal insufficiency,
hyperparathyroidism. Possible treatment option: donepezil
B. Possible other causes: vitamin B12 deficiency, depression. Possible treatment
option: memantine
C. Possible other causes: normal pressure hydrocephalus, syphilis. Possible
treatment option: rivastigmine
D. Possible other causes: hyperthyroidism, vitamin D deficiency. Possible
treatment option: galantamine
Correct Answer: A
Rationale: Hypothyroidism, adrenal insufficiency, and hyperparathyroidism are
reversible causes of dementia that must be ruled out before initiating treatment.
Donepezil is a cholinesterase inhibitor that is a rational first-line treatment option
for dementia, particularly Alzheimer's disease .
Question 8
An 80-year-old female patient diagnosed with Stage II Alzheimer's has a history of
irritable bowel syndrome. Which cholinergic drug may be the best choice for
treatment given the patient's gastrointestinal problems?
A. Donepezil (Aricept)
B. Rivastigmine (Exelon)
C. Galantamine (Razadyne)
D. Memantine (Namenda)
Correct Answer: A
Rationale: Donepezil (Aricept) is often the best choice for patients with
gastrointestinal problems because it has a more favorable GI side effect profile
compared to rivastigmine and galantamine. It is a selective acetylcholinesterase
inhibitor with once-daily dosing and lower incidence of GI adverse effects .
Question 9
The PMHNP is teaching parents about their child's new prescription for Ritalin.
What will the PMHNP include in the teaching?
A. The second dose should be taken at lunch
B. There are no risks for insomnia
C. There is only one daily dose, to be taken in the morning
D. There will be continued effects into the evening
